By Scott Murdoch SYDNEY (Reuters) -Chinese drug developer and producer Jiangsu Hengrui Pharmaceuticals will price its shares ...

COVID-19 cases are sharply increasing in parts of Asia, particularly Singapore and Hong Kong, driven by the fast-spreading ...

Health authorities in India are monitoring reports of rising Covid-19 cases in Singapore and Hong Kong, but fresh concerns ...

With total assets of $53.7 billion, FWD Group has launched its fourth IPO attempt in Hong Kong, tapping into surging investor ...

Several Southeast Asian countries, including Singapore, China, Thailand, and Hong Kong, are experiencing a resurgence of ...

Health authorities in densely-populated Hong Kong and Singapore have warned that Covid-19 cases are spiking, as a resurgent ...

Several parts of Asia, like Hong Kong, Singapore, China and Thailand, are seeing a sharp surge in the number of coronavirus ...

As Covid-19 cases surge in parts of Asia, including Singapore and Hong Kong, Indian health authorities have ramped up ...

Coronavirus cases are rising sharply in Hong Kong and Singapore, with health officials warning of a new wave across Asia.

At least five companies from mainland China or Hong Kong are planning IPOs, dual listings, or share placements in Singapore in the next 12 to 18 months, four sources said, as Chinese firms look to ...

Singapore’s transformation has been driven by a business-friendly regulatory environment and sustained investments in ...

SINGAPORE] Chinese electric vehicle battery maker Contemporary Amperex Technology Company Limited (CATL) has drawn strong ...